• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconGilead

Gilead

Page 3 of 4
Iris Network Student
Health
The First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By Sy MukherjeeDecember 19, 2017
Research Not Hysteria
Health
PHOTOS: The Incredible Advances We’ve Made in the War Against HIV on World AIDS Day
By Sy MukherjeeDecember 1, 2017
Iris Network Student
Health
Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By Sy MukherjeeNovember 16, 2017
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
Health
The FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way
By Sy MukherjeeOctober 19, 2017
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
Health
Gilead’s Deal to Buy Kite Pharma Is a Game-Changer
By Sy MukherjeeAugust 28, 2017
Hepatitis C drug can cure, if patients can get it
Health
The FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks
By Sy MukherjeeAugust 3, 2017
Gilead Just Paid $125 Million to Nab a Big Market Advantage
Health
Gilead Just Paid $125 Million to Nab a Big Market Advantage
By Sy MukherjeeFebruary 21, 2017
These 3 Ugly Patent Battles Could Rock Biopharma’s 2017
Health
These 3 Ugly Patent Battles Could Rock Biopharma’s 2017
By Sy MukherjeeJanuary 7, 2017
World AIDS Day Is Marked Around The World
Health
Why GSK’s Experimental HIV Drug Could Be a Safer Bet—And a Headache for Gilead
By Sy MukherjeeDecember 20, 2016
Hepatitis C drug can cure, if patients can get it
Health
Merck Won a Mammoth $2.5 Billion from Gilead After Its Hepatitis C Drug Patent Suit
By ReutersDecember 15, 2016
Wells Fargo CEO John Stumpf Testifies To The House Financial Services Committee
Finance
Wells Fargo’s John Stumpf Is the Latest Victim of ‘CEO of the Year’ Curse
By Jen WiecznerOctober 14, 2016
Why the Fight Against AIDS Still Matters, in One Chart
Health
Why the Fight Against AIDS Still Matters, in One Chart
By Matthew HeimerAugust 23, 2016
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
Health
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
By Sy MukherjeeAugust 1, 2016
Inside of a Gilead Sciences Lab
Health
The First-Ever Drug to Treat All Major Hep C Strains Just Got Approved
By Sy MukherjeeJune 29, 2016
New Hepatitis C wonder drug is costly
Health
Why Gilead May Not Have to Pay Merck $200 Million After All
By Sy MukherjeeJune 7, 2016
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Economy
Economists have found an answer to slowing cognitive decline: Avoid retiring early, study findsplaceholder alt text
By Sasha RogelbergJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.